Amikacin Sulphate 500 mg Injection

Description

Micakaz-500: The Strategic Clinical Defense Against Resistant Bacterial Infections

In the management of severe systemic infections, particularly those that have become resistant to standard antibiotics, the choice of treatment is a critical factor in patient recovery. Micakaz-500 (Amikacin Sulphate Injection I.P. 500mg) is a professional-grade, broad-spectrum aminoglycoside antibiotic engineered for intensive antibacterial intervention. It is a vital tool for eliminating life-threatening bacteria that affect the lungs, blood, and vital organs.

Micakaz-500 is a cornerstone of our Ethical Pharma Division. This injectable therapy is specifically designed to provide high bioavailability and a rapid therapeutic response, making it the gold standard for hospital-grade treatment of multi-drug resistant (MDR) pathogens.

Product Overview: What is Micakaz-500?

Micakaz-500 is a sterile, clinical-strength solution containing Amikacin Sulphate (500mg per 2ml). As a semi-synthetic aminoglycoside, Amikacin is uniquely stable against many of the enzymes that bacteria use to destroy other antibiotics like Gentamicin or Tobramycin. This makes Micakaz-500 exceptionally effective in critical care settings.

Manufactured in WHO-GMP certified facilities, every vial of Micakaz-500 is tested for the highest levels of purity and potency. Designed for Intramuscular (I.M.) or Intravenous (I.V.) administration, it ensures that the medication reaches the site of infection via the bloodstream with 100% efficiency, bypassing the limitations of oral therapy.

The Science of “Protein Synthesis Inhibition”

Micakaz-500 works through a specialized bactericidal mechanism that stops germs at the cellular level:

1. Ribosomal Binding: Amikacin molecules bind irreversibly to the bacterial 30S ribosomal subunit.
2. Genetic Misreading: This binding causes the bacteria to misread their genetic code, leading to the production of non-functional or “broken” proteins.
3. Cellular Collapse: Without the ability to create essential proteins, the bacterial cell membrane leaks, and the organism dies rapidly.
4. Enzymatic Stability: Its unique chemical structure protects it from being deactivated by bacterial enzymes, ensuring it remains active against resistant strains.

Key Benefits of Micakaz-500 Injection

• Beats Resistant Bacteria: Highly effective against “tough” Gram-negative bacteria that are resistant to multiple other antibiotic classes.
• Rapid Systemic Action: Direct I.V./I.M. delivery ensures therapeutic levels are achieved in the blood and tissues within minutes, which is critical for treating sepsis.
• Targeted Organ Reach: Effectively penetrates deep into the lungs, urinary tract, and soft tissues to eliminate localized infections.
• Synergistic Potential: Often used in combination with Beta-lactam antibiotics to provide a “double-strike” against severe, unknown infections.
• Clinically Proven Safety: Manufactured under strict quality controls with clear dosing guidelines to minimize the risk of side effects while maximizing healing.

Primary Clinical Applications (Indications)

Healthcare specialists and surgeons frequently prescribe Micakaz-500 for:

• Severe Respiratory Infections: Managing hospital-acquired pneumonia and lung abscesses.
• Septicemia: Providing a rapid, life-saving defense against bacteria in the bloodstream.
• Complicated UTIs: Treating deep-seated kidney infections (pyelonephritis) and resistant bladder infections.
• Bone and Joint Infections: Managing skeletal infections where deep-tissue penetration is required.
• Post-Surgical Protection: Preventing severe infections following abdominal or orthopedic surgeries.
• Meningitis: Occasionally used in specialized protocols for bacterial infections of the central nervous system.

PCD Pharma Franchise Opportunity: Grow with Novalab

As a high-demand critical care product, Micakaz-500 offers an exceptional opportunity for PCD Pharma Franchise partners:

• Hospital-Grade Product Segment: Target nursing homes, ICUs, and surgical centers with a product that is essential for emergency medicine.
• Exclusive Monopoly Rights: We provide exclusive territory rights to ensure your business grows without local competition.
• Marketing Excellence: Gain access to professional visual aids, product cards, and clinical literature (LBLs) to build strong relationships with physicians and surgeons.

Frequently Asked Questions 

1. Is Micakaz-500 stronger than other antibiotics?
   Micakaz-500 is specifically designed for infections that are “resistant” to other antibiotics. It is often the “next-step” treatment when first-line medicines fail.
2. How is this injection administered?
   It must be administered by a healthcare professional as a Deep Intramuscular (I.M.) injection or a Slow Intravenous (I.V.) infusion.
3. Why do I need blood tests during treatment?
   Since Amikacin is cleared by the kidneys, doctors often monitor kidney function and blood levels of the medicine to ensure the dose is perfectly balanced for your body.
4. How long does a typical course last?
   A typical course of Micakaz-500 usually lasts for 7 to 10 days. It is critical to complete the full course even if you start feeling better sooner.
5. Are there any side effects?
   Like all strong antibiotics, some patients may experience nausea. In rare cases, long-term use requires monitoring of hearing and kidney function. Always follow your doctor’s specific monitoring plan.
6. Can I take this if I am pregnant?
   Aminoglycosides are generally avoided during pregnancy unless necessary. Inform your doctor immediately if you are pregnant or planning to become pregnant.
7. How should the vial be stored?
   Store Micakaz-500 in a cool, dry place away from direct sunlight. The solution should be clear; do not use it if you notice any discoloration or particles.
8. Can I stop the treatment if my fever goes away?
   No. Stopping an antibiotic early can lead to the remaining bacteria becoming “superbugs.” You must complete the entire duration prescribed by your specialist.